What development phase is Moctanin in?

Moctanin is FDA-approved (marketed).

What is the generic name of Moctanin?

MONOCTANOIN is the generic (nonproprietary) name of Moctanin.

Last reviewed 2026-04-20 · How we verify

Moctanin (MONOCTANOIN)

FDA-approved approved Quality 10/100

At a glance

Generic name	MONOCTANOIN
Drug class	monoctanoin
Therapeutic area	Gastroenterology
Phase	FDA-approved
First approval	1985

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Safety, Tolerability, and Pharmacokinetics (PK) of Single and Multiple Ascending Oral Doses of iQ-007 (PHASE1)
Effect of Topical Agents With Various Antioxidant Containts on Photodamage Skin Induced (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
FDA label	Mechanism, indications, dosing, boxed warnings, drug interactions
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Moctanin CI brief — competitive landscape report
Moctanin updates RSS · CI watch RSS